Paper37460391
Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation.
Canarutto D and 4 others. Br Med Bull, 2023. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation. Papers, record 37460391. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37460391
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hematopoietic Stem Cell Transplantation | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Humans | |
| Genetic Therapy | |
| Tissue Donors |
Source PubMed
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35679480 | In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4. | Blood Adv | 2022 | https://conductscience.org/library/papers/35679480 | PubMed |
| 2 | 30905619 | Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response. | Cell Stem Cell | 2019 | https://conductscience.org/library/papers/30905619 | PubMed |
| 3 | 28034992 | Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone. | Haematologica | 2017 | https://conductscience.org/library/papers/28034992 | PubMed |
| 4 | 5654091 | Fate of chromosome-marked mouse bone marrow cells tranfused into normal syngeneic recipients. | Transplantation | 1968 | https://conductscience.org/library/papers/5654091 | PubMed |
| 5 | 32690879 | Characteristics of cells with engraftment capacity within CD34+ cell population upon G-CSF and Plerixafor mobilization. | Leukemia | 2020 | https://conductscience.org/library/papers/32690879 | PubMed |
| 6 | 9573004 | Lymphohematopoietic engraftment in minimally myeloablated hosts. | Blood | 1998 | https://conductscience.org/library/papers/9573004 | PubMed |
| 7 | 7537121 | Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. | Blood | 1995 | https://conductscience.org/library/papers/7537121 | PubMed |
| 8 | 30776910 | Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration. | Antivir Chem Chemother | 2019 | https://conductscience.org/library/papers/30776910 | PubMed |
| 9 | 24914142 | Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. | Blood | 2014 | https://conductscience.org/library/papers/24914142 | PubMed |
| 10 | 22951944 | Hematopoietic stem cell mobilization: updated conceptual renditions. | Leukemia | 2013 | https://conductscience.org/library/papers/22951944 | PubMed |
| 11 | 37001534 | Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial. | Lancet Haematol | 2023 | https://conductscience.org/library/papers/37001534 | PubMed |
| 12 | 35690693 | The cellular composition and function of the bone marrow niche after allogeneic hematopoietic cell transplantation. | Bone Marrow Transplant | 2022 | https://conductscience.org/library/papers/35690693 | PubMed |
| 13 | 12750697 | Bone marrow transplantation: how important is CD34 cell dose in HLA-identical stem cell transplantation? | Leukemia | 2003 | https://conductscience.org/library/papers/12750697 | PubMed |
| 14 | 35288539 | A systematic review and meta-analysis of gene therapy with hematopoietic stem and progenitor cells for monogenic disorders. | Nat Commun | 2022 | https://conductscience.org/library/papers/35288539 | PubMed |
| 15 | 34485596 | Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series. | Mol Ther Methods Clin Dev | 2021 | https://conductscience.org/library/papers/34485596 | PubMed |
| 16 | 18426988 | Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. | Blood | 2008 | https://conductscience.org/library/papers/18426988 | PubMed |
| 17 | 10947989 | Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. | Science | 2000 | https://conductscience.org/library/papers/10947989 | PubMed |
| 18 | 33054108 | History of hematopoietic cell transplantation: challenges and progress. | Haematologica | 2020 | https://conductscience.org/library/papers/33054108 | PubMed |
| 19 | 31890743 | Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson's Disease. | Mol Ther Methods Clin Dev | 2020 | https://conductscience.org/library/papers/31890743 | PubMed |
| 20 | 19270698 | Hematopoietic stem cell transplantation without irradiation. | Nat Methods | 2009 | https://conductscience.org/library/papers/19270698 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42225947 | Selection of human hematopoietic stem cells bearing the intended functional edit by transient AND-gate reporters. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/42225947 | PubMed |
| 42074029 | Clinical Trial Landscape of Gene-Edited Autologous Hematopoietic Stem Cells for Hemoglobinopathies and Immunodeficiencies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074029 | PubMed |
| 40578354 | Vascular endothelial growth factor-induced vascular permeability results in drastic and reversible hematopoietic stem cell mobilization. | Stem Cell Reports | 2025 | https://conductscience.org/library/papers/40578354 | PubMed |
| 40285354 | Clinical hematopoietic stem cell-based gene therapy. | Mol Ther | 2025 | https://conductscience.org/library/papers/40285354 | PubMed |
| 39314524 | Correction of osteopetrosis in the neonate oc/oc murine model after lentiviral vector gene therapy and non-genotoxic conditioning. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39314524 | PubMed |
| 39279550 | Lipid nanoparticle-mediated RNA delivery for immune cell modulation. | Eur J Immunol | 2024 | https://conductscience.org/library/papers/39279550 | PubMed |
| 39075608 | Donor and recipient hematopoietic stem and progenitor cells mobilization in liver transplantation patients. | Stem Cell Res Ther | 2024 | https://conductscience.org/library/papers/39075608 | PubMed |
| 38976142 | Role of Neurotransmitters in Steady State Hematopoiesis, Aging, and Leukemia. | Stem Cell Rev Rep | 2025 | https://conductscience.org/library/papers/38976142 | PubMed |
| 38970612 | International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced. | Cytotherapy | 2024 | https://conductscience.org/library/papers/38970612 | PubMed |
| 38843380 | A simplified G-CSF-free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model. | Blood Adv | 2024 | https://conductscience.org/library/papers/38843380 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37460391
GET https://conductscience.org/api/papers/v1/37460391/references?page=2